heart failure

January 16, 2020

Global effort tracks causes, treatment of acute heart failure

Patients in North America wait a median of three hours to receive intravenous therapy for acute heart failure, while no other region in the world waited for more than 1.2 hours, according to a global study whose lead author and co-primary investigator is Sean Collins, MD, MSc, professor of Emergency Medicine.

By Matt Batcheldor
March 28, 2019

Cardiac dysfunction in DMD

The protein MMP7 is elevated in blood from patients with Duchenne muscular dystrophy who have cardiac dysfunction, suggesting that it may be a biomarker for heart disease severity.

By Leigh MacMillan
June 7, 2018

Enzyme protects against obesity-related heart disease

Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.

By Sanjay Mishra
Iconic Baltimore inner city row houses.
January 9, 2018

Heart failure risk predicted by communities, not wealth

When buying and selling real estate, how often have you heard the realtor’s mantra — location, location, location? This is also the central theme of a recently released journal report on factors that can predict heart failure risk.

By Jessica Pasley
April 27, 2017

HIV-infected people have higher risk of heart failure

The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology.

By Jessica Pasley
January 5, 2017

Heart failure “dashboard”

A new computer algorithm developed at Vanderbilt could save billions of dollars in health care costs by identifying patients at risk for readmission after being hospitalized for heart failure.

By Sanjay Mishra
June 3, 2016

Pregnancy-related heart disorder clues

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure.
By Yan Su
April 14, 2016

Heart Institute celebrates LVAD program milestone

On April 7, a 48-year-old man from Bethpage, Tennessee, became the 300th person to receive a left ventricular assist device (LVAD) at Vanderbilt Heart and Vascular Institute (VHVI).
By Kathy Whitney
September 17, 2015

Heart repair factor

A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.
By Yan Su
August 20, 2015

New device monitors pulmonary artery pressures

For patients with heart failure, changes in pulmonary artery (PA) pressures are an early indication that their condition is worsening, even before they notice symptoms such as shortness of breath or weight gain.
By Kathy Whitney
May 21, 2015

Study seeks to bolster outcomes for acute heart failure patients

With support from a three-year, $2 million research grant from Patient-Centered Outcomes Research Institute (PCORI), Vanderbilt University Medical Center and the American Heart Association are teaming up to study heart failure care in the Emergency Department.
By Kathy Whitney
March 19, 2015

New research group oversees studies in advanced heart failure

Vanderbilt’s Department of Cardiac Surgery has developed an Advanced Heart Failure Clinical and Translational Research Group that serves as a central research resource for advanced heart failure surgeons and cardiologists.
By Kathy Whitney
March 14, 2013

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.
By Kathy Whitney
1 2 3